Evidence map›Paper›PMID 42383549›Full record

ArticleAdvanced materials (Deerfield Beach, Fla.)2026

Zein-Ceria Hybrid Microparticles Enable Long-Term ROS-Scavenging Oxygenation for Osteogenic Microtissues Engineering.

Hayeon Byun, Seok Gyu Han, Niels Willemen, Eunji Park, Kannan Govindaraj, Seol-Ha Jeong, Oju Jeon, Eben Alsberg, Jeroen Leijten, Heungsoo Shin and 1 more

Abstract read
In one paragraph

Article in Advanced materials (Deerfield Beach, Fla.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Hayeon ByunDivision of Engineering in Medicine, Department of Medicine, Harvard Medical School, and Brigham and Women's Hospital, Cambridge, Massachusetts, USA.
Seok Gyu HanDivision of Engineering in Medicine, Department of Medicine, Harvard Medical School, and Brigham and Women's Hospital, Cambridge, Massachusetts, USA.
Niels WillemenLeijten Laboratory, Department of Bioengineering Technologies, Faculty of Science and Technology, TechMed Centre, University Twente, Enschede, Netherlands.
Eunji ParkDepartment of Bioengineering, Hanyang University, Seoul, Republic of Korea.
Kannan GovindarajDivision of Engineering in Medicine, Department of Medicine, Harvard Medical School, and Brigham and Women's Hospital, Cambridge, Massachusetts, USA.
Seol-Ha JeongDivision of Engineering in Medicine, Department of Medicine, Harvard Medical School, and Brigham and Women's Hospital, Cambridge, Massachusetts, USA.
Oju JeonDepartment of Biomedical Engineering, University of Illinois Chicago, Chicago, Illinois, USA.
Eben AlsbergDepartment of Biomedical Engineering, University of Illinois Chicago, Chicago, Illinois, USA.
Jeroen LeijtenLeijten Laboratory, Department of Bioengineering Technologies, Faculty of Science and Technology, TechMed Centre, University Twente, Enschede, Netherlands.
Heungsoo ShinDepartment of Bioengineering, Hanyang University, Seoul, Republic of Korea.
Su Ryon ShinDivision of Engineering in Medicine, Department of Medicine, Harvard Medical School, and Brigham and Women's Hospital, Cambridge, Massachusetts, USA.

Funding

Suturable bioprinted vascularized muscle constructs for treatment of skeletal muscle lossR01AR077132 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI SHIN, SU RYON, TAMAYOL, ALI · 2021 to 2025
$2.6M
Oxygen generating bioinks for 3D printed bone implantsR01AR074234 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI SHIN, SU RYON · 2018 to 2022
$1.9M
National Research Foundation of Korea RS-2023-00207983NIAMS NIH HHS R01 AR074234NIAMS NIH HHS R01 AR077132NIH HHS R01AR074234NIH HHS R01AR077132
6 · The paper itself

Abstract

Oxygen- and biological cue-deprived microenvironments formed during tissue regeneration severely limit cell survival and differentiation, resulting in long-term structural and functional deficits. However, conventional oxygen-releasing biomaterials often exhibit burst releases, with the vast majority of oxygen released during the first few days, which is associated with high levels of concomitant reactive oxygen species (ROS)-derived oxidative stress and a lack of bioactive factors. Here, we report a hierarchically engineered zein-ceria hybrid microparticle that enables sustained ROS-neutral oxygenation for over 40 days and supplies an osteoinductive factor. A hydrophobic zein core stabilizes the oxygen source and suppresses burst release, while a ceria nanozyme-integrated shell continuously scavenges excess ROS via redox cycling. Biocompatible surface engineering enables the seamless integration of these microparticles within stem cell spheroids, which markedly enhances cell survival under anoxia. Their biofunctional surface supports enzymatic protein immobilization under physiological conditions, enabling spontaneous osteogenesis of engineered bone microtissues. In a severely oxygen-deprived mouse calvarial defect model, the engineered microtissues accelerated bone regeneration. Our biomaterial design enables control of burst oxygen release, ROS modulation, and growth factor release, built on a zein-ceria double-layer architecture, offering a modular platform that broadens the utility of oxygenating and bioactive micromaterials in regenerative medicine.

Indexed as

CeriumOsteogenesisOxygenReactive Oxygen SpeciesTissue EngineeringZeinAnimalsBiocompatible MaterialsBone RegenerationCell SurvivalMiceBiocompatible MaterialsCeriumOxygenReactive Oxygen SpeciesZeinceriaosteogenesisosteoinductive factoroxygenating micromaterialsregenerative medicinezein

Identifiers

PMID42383549
PMCPMC13449137

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.